An article entitled US and EU regulations for drug delivery systems: development considerations for innovative products authored by Voisin Consulting Life Sciences is available in the February 2012 issue of Scrip Regulatory Affairs. It provides an analysis of the current regulatory framework and challenges surrounding development and registration of innovative combination of drug and delivery system in the EU and US.
Contact vcrennes for more details.
